Viral Infection and Respiratory Illness Universal Study[VIRUS]
Sponsored by Mayo Clinic
Researchers are creating a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.
About COVID-19
Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.
How is this study designed?
Study Type: Observational Estimated Enrollment: 50000 participants Official Title: Viral Infection and Respiratory Illness Universal StudyRegistry and Validation of C2D2 (Critical Care Data Dictionary) Actual Study Start Date: March 30, 2020 Estimated Study Completion Date: April 30, 2021
Who is this study for?
Study Population COVID-19 Hospitalized patients
Inclusion Criteria*:
- COVID-19 PCR positive (within 7 days)
- COVID-19 PCR pending
- COVID-19 high clinical suspicion
Exclusion Criteria*:
- Non COVID-19 related admissions
- Repeated Admission to ICUs/Hospital
* Additional criteria apply. Please speak with the study team for further information.
What should I expect?
VIRUS is a prospective, cross-sectional, observational study and registry of all eligible adult and pediatric patients who are admitted to a hospital. There is no intervention or patient interaction. Only de-identified data will be used for analysis.
Have questions or need help?
For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form and you'll be connected to the team.